149 related articles for article (PubMed ID: 26365874)
1. Cancer arises from stem cells: opportunities for anticancer drug discovery.
López-Lázaro M
Drug Discov Today; 2015 Nov; 20(11):1285-7. PubMed ID: 26365874
[No Abstract] [Full Text] [Related]
2. Cancer stem cells as a target population for drug discovery.
Bouvard C; Barefield C; Zhu S
Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells as the relevant biomass for drug discovery.
Winquist RJ; Furey BF; Boucher DM
Curr Opin Pharmacol; 2010 Aug; 10(4):385-90. PubMed ID: 20630801
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell targeted therapy: progress amid controversies.
Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Shamaileh HA; Yin W; Zhou SF; Zhao X; Duan W
Oncotarget; 2015 Dec; 6(42):44191-206. PubMed ID: 26496035
[TBL] [Abstract][Full Text] [Related]
5. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.
Zhou BB; Zhang H; Damelin M; Geles KG; Grindley JC; Dirks PB
Nat Rev Drug Discov; 2009 Oct; 8(10):806-23. PubMed ID: 19794444
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell targeting: are we there yet?
Jung Y; Kim WY
Arch Pharm Res; 2015 Mar; 38(3):414-22. PubMed ID: 25666873
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells: a challenging paradigm for designing targeted drug therapies.
Khan IN; Al-Karim S; Bora RS; Chaudhary AG; Saini KS
Drug Discov Today; 2015 Oct; 20(10):1205-16. PubMed ID: 26143148
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modeling in cancer drug discovery.
Wang Z; Deisboeck TS
Drug Discov Today; 2014 Feb; 19(2):145-50. PubMed ID: 23831857
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profiles of cancer cells.
Griffin JL; Shockcor JP
Nat Rev Cancer; 2004 Jul; 4(7):551-61. PubMed ID: 15229480
[No Abstract] [Full Text] [Related]
10. Factors influencing development of new therapeutics for oncology.
Winquist RJ; Boucher DM
Curr Opin Pharmacol; 2010 Aug; 10(4):353-5. PubMed ID: 20634136
[No Abstract] [Full Text] [Related]
11. Cancer stem cells in the crosshairs.
Schmidt C
Cancer Discov; 2012 May; 2(5):384. PubMed ID: 22588862
[No Abstract] [Full Text] [Related]
12. Anticancer drug discovery in the future: an evolutionary perspective.
Ma X; Wang Z
Drug Discov Today; 2009 Dec; 14(23-24):1136-42. PubMed ID: 19800414
[TBL] [Abstract][Full Text] [Related]
13. Promising strategy developed to target drug-resistant cancer cells.
Thorne J
Future Med Chem; 2014 Apr; 6(6):603. PubMed ID: 25028759
[No Abstract] [Full Text] [Related]
14. Targeted therapy of cancer stem cells: science or fiction.
Ogris M; Roidl A
Ther Deliv; 2013 Feb; 4(2):135-8. PubMed ID: 23343151
[No Abstract] [Full Text] [Related]
15. Zebrafish xenograft models of cancer and metastasis for drug discovery.
Brown HK; Schiavone K; Tazzyman S; Heymann D; Chico TJ
Expert Opin Drug Discov; 2017 Apr; 12(4):379-389. PubMed ID: 28277839
[TBL] [Abstract][Full Text] [Related]
16. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Kong D; Yamori T
Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
18. Serendipity in Cancer Drug Discovery: Rational or Coincidence?
Prasad S; Gupta SC; Aggarwal BB
Trends Pharmacol Sci; 2016 Jun; 37(6):435-450. PubMed ID: 27083322
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology for cancer drug discovery: are we there yet?
Azmi AS
Future Med Chem; 2012 May; 4(8):939-41. PubMed ID: 22650234
[No Abstract] [Full Text] [Related]
20. Cancer stem cells: implications for cancer treatment and prevention.
Kakarala M; Wicha MS
Cancer J; 2007; 13(5):271-5. PubMed ID: 17921723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
